283 related articles for article (PubMed ID: 19265297)
1. [Relapsed acute myeloid leukemia with Down syndrome showing long disease-free survival after bone marrow transplantation].
Daifu T; Kato I; Matubara H; Abe D; Uryu K; Tokumasu M; Umeda K; Watanabe K; Izawa K; Asai K; Nakahata T; Adachi S
Rinsho Ketsueki; 2009 Feb; 50(2):73-7. PubMed ID: 19265297
[TBL] [Abstract][Full Text] [Related]
2. Unrelated donor bone marrow transplantation for acute mixed lineage (myeloid and B-lymphoid lineage) leukemia in an adult with Down syndrome.
Takagi K; Yoshida A; Kinoshita K; Iwashima D; Imamaura S; Iwasaki H; Tsutani H; Ueda T
Ann Hematol; 2003 Apr; 82(4):236-40. PubMed ID: 12707727
[TBL] [Abstract][Full Text] [Related]
3. Stem cell transplantation as consolidation therapy for children in first-remission AML: a single-center report.
Berger M; Ferrero I; Vassallo E; Gastaldo L; Carraro F; Biasin E; Madon E; Fagioli F
Pediatr Hematol Oncol; 2005; 22(7):597-608. PubMed ID: 16166053
[TBL] [Abstract][Full Text] [Related]
4. Unrelated donor bone marrow transplantation using a chemotherapy-only preparative regimen for adults with high-risk acute myelogenous leukemia.
Ayash LJ; Ratanatharathorn V; Braun T; Silver SM; Reynolds CM; Uberti JP
Am J Hematol; 2007 Jan; 82(1):6-14. PubMed ID: 16986128
[TBL] [Abstract][Full Text] [Related]
5. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.
Yang DH; Lee JJ; Mun YC; Shin HJ; Kim YK; Cho SH; Chung IJ; Seong CM; Kim HJ
Am J Hematol; 2007 Jan; 82(1):1-5. PubMed ID: 16986129
[TBL] [Abstract][Full Text] [Related]
6. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
[TBL] [Abstract][Full Text] [Related]
7. Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy.
Brandwein JM; Gupta V; Schuh AC; Schimmer AD; Yee K; Xu W; Messner HA; Lipton JH; Minden MD
Am J Hematol; 2008 Jan; 83(1):54-8. PubMed ID: 17696207
[TBL] [Abstract][Full Text] [Related]
8. Long-term remission of APL with a second allogeneic BMT after CNS relapse following HLA-identical allogeneic BMT.
Classen CF; Debatin KM; Friedrich W; Schulz AS
Bone Marrow Transplant; 2003 Oct; 32(8):843-6. PubMed ID: 14520432
[TBL] [Abstract][Full Text] [Related]
9. Donor lymphocyte infusion induced molecular remission in relapse of acute myeloid leukaemia after allogeneic bone marrow transplantation.
Au WY; Lie AK; Lee CK; Liang R; Kwong YL
Bone Marrow Transplant; 1999 Jun; 23(11):1201-3. PubMed ID: 10382962
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.
Kudo K; Kojima S; Tabuchi K; Yabe H; Tawa A; Imaizumi M; Hanada R; Hamamoto K; Kobayashi R; Morimoto A; Nakayama H; Tsuchida M; Horibe K; Kigasawa H; Tsukimoto I;
J Clin Oncol; 2007 Dec; 25(34):5442-7. PubMed ID: 18048827
[TBL] [Abstract][Full Text] [Related]
11. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
13. Unrelated donor bone marrow transplantation for acute leukemia in patients with Down's syndrome.
Pawlowska AB; Davies SM; Orchard PJ; Wagner JE; Ramsay NK
Bone Marrow Transplant; 1996 Aug; 18(2):453-5. PubMed ID: 8864463
[TBL] [Abstract][Full Text] [Related]
14. Isolated extramedullary relapse presenting as autologous lymphocyte response.
Imataki O; Ohnishi H; Kitanaka A; Kubota Y; Tanaka T; Ishida T
Am J Hematol; 2008 Jun; 83(6):512-4. PubMed ID: 18306363
[TBL] [Abstract][Full Text] [Related]
15. Donor lymphocyte infusions for post-transplant relapse of refractory anemia with excess blasts and monosomy 7.
Skinner R; Velangi M; Bown N
Pediatr Blood Cancer; 2008 Mar; 50(3):670-2. PubMed ID: 17253642
[TBL] [Abstract][Full Text] [Related]
16. GATA1 mutations in acute leukemia in children with Down syndrome.
Magalhães IQ; Splendore A; Emerenciano M; Figueiredo A; Ferrari I; Pombo-de-Oliveira MS
Cancer Genet Cytogenet; 2006 Apr; 166(2):112-6. PubMed ID: 16631466
[TBL] [Abstract][Full Text] [Related]
17. Comparable outcomes of HLA-matched unrelated and HLA-identical sibling donor bone marrow transplantation for childhood acute myeloid leukemia in first remission.
Lee DH; Kwon YJ; Lim J; Kim Y; Han K; Chung NG; Jeong DC; Cho B; Kim HK
Pediatr Transplant; 2009 Mar; 13(2):210-6. PubMed ID: 18627512
[TBL] [Abstract][Full Text] [Related]
18. [Philadelphia chromosome-positive acute lymphoblastic leukemia with monosomy 7 successfully treated with intermediate- and high-dose ara-C].
Hatsuse M; Shimazaki C; Tsubakimoto Y; Ochiai N; Okano A; Ashihara E; Inaba T; Fujita N; Nakagawa M
Rinsho Ketsueki; 2001 Feb; 42(2):115-8. PubMed ID: 11280917
[TBL] [Abstract][Full Text] [Related]
19. Nonmyeloablative allogeneic bone marrow transplantation for orbital granulocytic sarcoma associated with t(8;21)(q22;q22) in acute myeloid leukemia.
Hung GY; Chiou TJ; Hsieh YL; Chen PM; Hwang B
Bone Marrow Transplant; 2002 Jan; 29(1):67-70. PubMed ID: 11840147
[TBL] [Abstract][Full Text] [Related]
20. Unique clinical and biological features of leukemia in Down syndrome children.
Xavier AC; Ge Y; Taub J
Expert Rev Hematol; 2010 Apr; 3(2):175-86. PubMed ID: 21083461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
